v3.26.1
STOCK OPTION PLAN AND STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF GRANTED AND ISSUED STOCK AWARDS

The following table summarizes the Company’s granted and issued stock awards in the years ended December 31, 2025, and 2024:

   

Issuances under the 2021 Stock Plan in the period January 1 and December 31, 2024

 

Date     # Shares   Amount   Price/Share   Type  Notice
1/01/2024      5,288,687   $90,856   $0.017       
3/22/2024     211,269    21,338    0.101   stipend  affiliate
3/22/2024      72,423    7,315    0.101   stipend   
3/22/2024     979,191    101,835    0.104   bonus  affiliate
3/22/2024      1,520,808    158,164    0.104   bonus   
4/19/2024     241,938    30,000    0.124   stipend  affiliate
4/19/2024      86,246    10,695    0.124   stipend   
8/14/2024     454,546    45,455    0.100   stipend  affiliate
8/14/2024      84,646    8,464    0.100   stipend   
10/25/2024  *   412,380    40,000    0.097   stipend  affiliate
10/25/2024      155,091    15,044    0.097   stipend   
10/25/2024  **   (3,597,529)   (7,591)   0.002   forfeited  affiliate
10/25/2024  **   (389,595)   (40,518)   0.104   forfeited  affiliate
12/31/2024      5,520,101   $481,075   $0.087       

 

Issuances under the 2021 Stock Plan in the period January 1 and December 31, 2025

 

Date     # Shares   Amount   Price/Share   Type  Notice
1/01/2025      5,520,101   $481,075   $0.087       
1/06/2025  *   634,921    43,172    0.068   stipend  affiliates
1/06/2025      164,730    11,202    0.068   stipend   
1/06/2025  *   1,315,780    88,294    0.067   bonus  affiliates
1/06/2025      1,184,221    80,098    0.068   bonus   
5/12/2025  *   156,255    21,876    0.140   stipend  affiliates
5/12/2025      110,384    15,454    0.140   stipend   
11/14/2025  *   771,760    53,946    0.070   stipend  affiliates
11/14/2025      204,692    14,308    0.070   stipend   
12/31/2025      10,062,844   $809,407   $0.080       

 

  The Company claims an exemption from the registration requirements of the Securities Act for the Compensatory Benefit Plan pursuant to Rule 701 of the Securities Act.
* The shares were issued as Preferred Shares, but are for comparison purposes expressed as Common share equivalents in this table.
** The shares were forfeited in connection with the NDPD acquisition in October 2024. For comparative purposes shares issued within the 2021 stock plan are adjusted for grant availability purposes only, see also note 6

 

Shares awarded, but not yet issued, under the 2021 Stock Plan for the year ended December 31, 2025:

 

Date     # Shares   Amount   Price/Share   Type  Notice
12/31/2025  *   1,081,875   $82,006   $0.076   stipend  affiliate
12/31/2025      150,250    11,389    0.076   stipend   
12/31/2025      1,232,125   $93,395   $0.076       
SCHEDULE OF FAIR MARKET VALUE

Total number of shares awarded from the 2021 Plan

  

    Number of
Shares
    Fair Value
per Share
    Weighted
Average
Market Value
per Share
 
Shares Issued as of January 1, 2024     5,288,687     $ 0.001 – 0.55     $ 0.02  
Shares Issued     4,218,538       0.097 – 0.12       0.10  
Shares Retired     (3,987,124 )     0.002 – 0.10       0.01  
Shares Issued as of December 31, 2024     5,520,101     $ 0.001 – 0.55     $ 0.09  
Shares Issued     4,542,742       0.070 – 0.14       0.07  
Shares Issued as of December 31, 2025     10,062,843     $ 0.001 – 0.55     $ 0.08  
SCHEDULE OF STOCK OPTIONS ACTIVITY

As at December 31, 2025, there was no unrecognized compensation expense related to non-vested stock option awards. The following table summarizes the Company’s stock option activity for the year ended December 31, 2025, and 2024:

  

    Number of
Options
    Exercise
Price
per Share
    Weighted
Average
Exercise Price
per Share
 
Outstanding as of January 1, 2024     335,000     $ 0.001 – 0.95     $ 0.62  
Granted     —       —       —  
Exercised     —       —       —  
Options forfeited/cancelled     (335,000 )     0.001 – 0.95       0.62  
Outstanding as of December 31, 2024     —     $ —     $ —  
Granted     —       —       —  
Exercised     —       —       —  
Options forfeited/cancelled     —       —       —  
Outstanding as of December 31, 2025     —     $ —     $ —